The 2026 WADA Prohibited List includes myostatin inhibitors and related agents in section S4.3, prohibited at all times. Athletes should check their applicable anti-doping rules and qualified support before using any substance.[1]
- Official document
- WADA 2026 Prohibited List
- Section
- S4.3
- Timing
- In and out of competition
What does the list include?
Section S4.3 covers agents preventing activin receptor IIB activation. Examples include receptor decoys, receptor antibodies, myostatin-binding proteins, and antibodies targeting myostatin or its precursors. The list names examples such as ACE-031, bimagrumab, follistatin, and apitegromab.[1]
The category is not limited to one marketing term. A product described as a “research peptide” can still raise a sports-rule question based on what the substance does.
Does “at all times” include outside competition?
Yes. The relevant category is prohibited both in and out of competition under the 2026 List.[1] That makes it inappropriate to assume that a competition date is the only relevant time.
Use the current official list and the rules of your sport or anti-doping organization. This page explains the document checked on October 10, 2026; it is not an individual eligibility ruling.
Does FDA approval make a treatment permitted in sport?
Medical regulation and anti-doping eligibility are separate systems. A medicine’s disease-specific approval does not automatically establish that an athlete may use it under sports rules.
If a medical treatment is involved, discuss it with the treating clinician and the responsible anti-doping organization, including any applicable therapeutic-use-exemption process. Do not infer permission from a medicine’s presence on the market.
What should an athlete verify?
Verify the exact substance rather than only a brand or product category. Keep the ingredient information and source documents available when asking for guidance. Similar names can refer to different preparations.
For help understanding the terms, read the introductory guide. For questions about a health claim, use the clinician discussion checklist. Neither page replaces authoritative anti-doping advice.
Questions, answered.
Are only the examples named in the list prohibited?
The relevant WADA category is broader than its examples. Check the complete current category and your anti-doping organization’s guidance.
Does this page decide whether I can compete?
No. Eligibility depends on applicable rules and individual circumstances. The relevant organization is the authoritative source.
Sources & further reading
Primary research and official records used for this page. Study results apply to the populations and interventions described.
- 2026 WADA Prohibited List, section S4.3World Anti-Doping Agency · Effective January 1, 2026 · PDF